Literature DB >> 1485020

Hemorrhagic detachment of the internal limiting membrane after penetrating ocular injury.

S R Russell1, G S Hageman.   

Abstract

During surgery to remove an intraocular gunshot pellet, a loculated "preretinal" hemorrhage was identified. This provided an opportunity to evaluate the structural identity of the inner wall, presumably representing detached posterior vitreous. The preretinal membrane was excised and evaluated using lectin histochemical analysis. All lectins tested bound to the excised tissue, supporting the conclusion that the membrane was a hemorrhagic internal limiting membrane detachment resulting from direct penetrating ocular injury. During intraoperative biomicroscopic examination, this detachment was indistinguishable from a subhyaloid hemorrhage. Because there are no natural history studies on internal limiting membrane loss and damage to retinal visual function, caution is urged in the surgical management of these lesions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1485020     DOI: 10.1097/00006982-199212040-00009

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

1.  Sub-inner limiting membrane haemorrhage: causes and treatment with vitrectomy.

Authors:  Karolien De Maeyer; Rita Van Ginderdeuren; Laurence Postelmans; Peter Stalmans; Joachim Van Calster
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

2.  Subhyaloidal and macular haemorrhage: localisation and treatment strategies.

Authors:  Stefan Mennel
Journal:  Br J Ophthalmol       Date:  2007-07       Impact factor: 4.638

3.  Successful Resolution of Preretinal Haemorrhage with Intravitreal Ranibizumab.

Authors:  Baharuddin Noorlaila; Embong Zunaina; Mohd-Noor Raja-Azmi
Journal:  Case Rep Ophthalmol Med       Date:  2016-10-09

4.  Macular hemorrhage after laser exposure and cannabinoid intake during a disco party.

Authors:  Federica Fossataro; Alfredo Pece; Maria Belotti; Eustachio Maragno
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.